David Kirn, Chief Executive Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 25,846 shares at $22.49 ($581K) on 2024-07-10, disclosed to the SEC on 2024-07-12.
Scheduled sale ($581k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.49 | 12,923 | $291K | 50.0% |
| 2 | $22.49 | 12,923 | $291K | 50.0% |
| Total | $22.49 avg | 25,846 | $581K | 100% |
| Filing → |
| FDMT | SELL | 2026-08-21 | $1.1M | — | Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |